Stock of the Day for November 28, 2024

Johnson & Johnson Stock Report

Johnson & Johnson
JNJ 90-day performance NYSE:JNJ Johnson & Johnson
Current Price
$178.10
-0.40 (-0.22%)
(As of 09/12/2025 03:59 PM ET)
30 Day Performance
0.76%
  
 
90 Day Performance
14.72%
  
 
1 Year Performance
7.60%
  
 
Market Capitalization
$428.93B
P/E Ratio
19.05
Dividend Yield
2.92%

About Johnson & Johnson

Johnson & Johnson (NYSE: JNJ) is a diversified global healthcare company that develops, manufactures and sells a broad range of products in three primary business segments: Pharmaceuticals, Medical Devices and Consumer Health. Founded in 1886 by brothers Robert Wood Johnson, James Wood Johnson and Edward Mead Johnson, the company pioneered sterile surgical dressings and has since expanded into prescription medicines, diagnostics and advanced medical technologies, as well as over-the-counter healthcare products.

In its Pharmaceuticals segment, Johnson & Johnson researches and commercializes treatments in areas such as immunology, oncology, neuroscience and infectious diseases. The Medical Devices segment offers a wide array of surgical systems, orthopaedic devices, cardiovascular care solutions and vision care products. Within Consumer Health, the company markets well-known brands in skin care, baby care, wound care, oral hygiene and women’s health. Together, these divisions serve healthcare professionals, consumers and patients around the world.

Headquartered in New Brunswick, New Jersey, Johnson & Johnson operates in more than 60 countries and sells products in virtually every market worldwide. The company maintains research and development facilities across North America, Europe and Asia, supporting collaborations with academic institutions and biotechnology firms. As of 2022, Johnson & Johnson is led by Chairman and Chief Executive Officer Joaquin Duato, under whose leadership the company continues to pursue innovation and sustainable growth within the global healthcare industry.

JNJ Company Calendar

JUL. 16, 2025
Last Earnings
AUG. 26, 2025
Ex-Dividend for 9/9 Dividend
SEP. 9, 2025
Dividend Payable
SEP. 14, 2025
Today
OCT. 14, 2025
Next Earnings (Estimated)
DEC. 31, 2025
Fiscal Year End

Recent Johnson & Johnson News

Sage Capital Advisors llc Buys 1,650 Shares of Johnson & Johnson $JNJ
Capital Market Strategies LLC Decreases Stake in Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Stock Holdings Cut by InvesTrust
Jacobs & Co. CA Sells 2,195 Shares of Johnson & Johnson $JNJ
Marotta Asset Management Sells 1,533 Shares of Johnson & Johnson $JNJ
Neville Rodie & Shaw Inc. Sells 2,855 Shares of Johnson & Johnson $JNJ
Good Steward Wealth Advisors LLC Sells 1,797 Shares of Johnson & Johnson $JNJ
Park National Corp OH Lowers Holdings in Johnson & Johnson $JNJ
Versant Capital Management Inc Raises Stake in Johnson & Johnson $JNJ
This report was written by MarketBeat.com on September 14, 2025. This report first appeared on MarketBeat.com.